These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 26663176)
1. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers. Saumet A; Lecellier CH Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs: potential biomarkers for common malignancies. Khoury S; Tran N Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901 [TBL] [Abstract][Full Text] [Related]
3. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics. Banwait JK; Bastola DR Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261 [TBL] [Abstract][Full Text] [Related]
4. The potential of microRNAs in personalized medicine against cancers. Saumet A; Mathelier A; Lecellier CH Biomed Res Int; 2014; 2014():642916. PubMed ID: 25243170 [TBL] [Abstract][Full Text] [Related]
5. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis. Ferracin M; Negrini M Expert Rev Mol Diagn; 2015; 15(10):1369-81. PubMed ID: 26338209 [TBL] [Abstract][Full Text] [Related]
6. [Cancer: three eras of personalized medicine]. Jordan B Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of microRNA and mRNA expression signatures in cancer. Li MH; Fu SB; Xiao HS Acta Pharmacol Sin; 2015 Oct; 36(10):1200-11. PubMed ID: 26299954 [TBL] [Abstract][Full Text] [Related]
8. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Mansoori B; Mohammadi A; Shirjang S; Baradaran B Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers for personalized medicine in GI cancers. Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566 [TBL] [Abstract][Full Text] [Related]
10. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality. MacConaill LE; Lindeman NI; Rollins BJ JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886 [No Abstract] [Full Text] [Related]
11. Cancer molecular markers: A guide to cancer detection and management. Nair M; Sandhu SS; Sharma AK Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis. Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in cancer: biomarkers, functions and therapy. Hayes J; Peruzzi PP; Lawler S Trends Mol Med; 2014 Aug; 20(8):460-9. PubMed ID: 25027972 [TBL] [Abstract][Full Text] [Related]
14. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy. Qin C; Huang RY; Wang ZX Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059 [TBL] [Abstract][Full Text] [Related]
15. microRNAs as cancer biomarkers. Flatmark K; Høye E; Fromm B Scand J Clin Lab Invest Suppl; 2016; 245():S80-3. PubMed ID: 27542003 [TBL] [Abstract][Full Text] [Related]
16. Exploiting microRNA Specificity and Selectivity: Paving a Sustainable Path Towards Precision Medicine. Santulli G Adv Exp Med Biol; 2015; 888():1-3. PubMed ID: 26663175 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine. Smith B; Agarwal P; Bhowmick NA Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080 [TBL] [Abstract][Full Text] [Related]
18. microRNAs: Emerging players in oral cancers and inflammatory disorders. Kulkarni V; Uttamani JR; Naqvi AR; Nares S Tumour Biol; 2017 May; 39(5):1010428317698379. PubMed ID: 28459366 [TBL] [Abstract][Full Text] [Related]
19. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine. Kamel HFM; Al-Amodi HSAB Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and cancer: towards a personalized medicine. Fabbri M Curr Mol Med; 2013 Jun; 13(5):751-6. PubMed ID: 23642056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]